Market Closed -
Bombay S.E.
11:00:47 14/05/2024 BST
|
5-day change
|
1st Jan Change
|
346.4
INR
|
-0.39%
|
|
+0.17%
|
-13.53%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
9,890
|
7,638
|
4,511
|
19,748
|
23,749
|
11,838
|
Enterprise Value (EV)
1 |
11,163
|
9,421
|
4,839
|
20,352
|
25,068
|
13,983
|
P/E ratio
|
29.3
x
|
13.4
x
|
5.23
x
|
19.4
x
|
44.6
x
|
60
x
|
Yield
|
0.23%
|
0.44%
|
1.86%
|
0.43%
|
0.21%
|
0.14%
|
Capitalization / Revenue
|
1.95
x
|
1.01
x
|
0.59
x
|
2.79
x
|
2.73
x
|
1.39
x
|
EV / Revenue
|
2.21
x
|
1.25
x
|
0.64
x
|
2.87
x
|
2.89
x
|
1.65
x
|
EV / EBITDA
|
17.3
x
|
8.13
x
|
3.83
x
|
13.1
x
|
27.4
x
|
26.5
x
|
EV / FCF
|
-69.5
x
|
-16.6
x
|
3.3
x
|
-63.5
x
|
-34
x
|
-17.9
x
|
FCF Yield
|
-1.44%
|
-6.01%
|
30.3%
|
-1.57%
|
-2.94%
|
-5.6%
|
Price to Book
|
2.17
x
|
1.95
x
|
0.97
x
|
3.54
x
|
3.92
x
|
1.89
x
|
Nbr of stocks (in thousands)
|
45,495
|
33,654
|
33,654
|
33,654
|
33,654
|
33,654
|
Reference price
2 |
217.4
|
227.0
|
134.0
|
586.8
|
705.7
|
351.8
|
Announcement Date
|
26/09/18
|
28/08/19
|
21/08/20
|
02/07/21
|
01/07/22
|
24/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,060
|
7,547
|
7,599
|
7,088
|
8,688
|
8,491
|
EBITDA
1 |
644.7
|
1,159
|
1,264
|
1,550
|
916.5
|
527.5
|
EBIT
1 |
498.1
|
982.6
|
1,076
|
1,385
|
757.3
|
348.8
|
Operating Margin
|
9.84%
|
13.02%
|
14.16%
|
19.54%
|
8.72%
|
4.11%
|
Earnings before Tax (EBT)
1 |
429.7
|
831.7
|
1,029
|
1,370
|
758.8
|
274.8
|
Net income
1 |
249.8
|
571.4
|
861.9
|
1,019
|
533
|
197.4
|
Net margin
|
4.94%
|
7.57%
|
11.34%
|
14.38%
|
6.14%
|
2.33%
|
EPS
2 |
7.423
|
16.98
|
25.61
|
30.29
|
15.84
|
5.867
|
Free Cash Flow
1 |
-160.7
|
-566
|
1,467
|
-320.5
|
-737.3
|
-783.2
|
FCF margin
|
-3.17%
|
-7.5%
|
19.31%
|
-4.52%
|
-8.49%
|
-9.22%
|
FCF Conversion (EBITDA)
|
-
|
-
|
116.05%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
170.21%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.5000
|
1.000
|
2.500
|
2.500
|
1.500
|
0.5000
|
Announcement Date
|
26/09/18
|
28/08/19
|
21/08/20
|
02/07/21
|
01/07/22
|
24/07/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,273
|
1,784
|
327
|
605
|
1,319
|
2,146
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.974
x
|
1.539
x
|
0.259
x
|
0.39
x
|
1.439
x
|
4.068
x
|
Free Cash Flow
1 |
-161
|
-566
|
1,467
|
-321
|
-737
|
-783
|
ROE (net income / shareholders' equity)
|
7.64%
|
15.7%
|
20.1%
|
20%
|
9.17%
|
3.21%
|
ROA (Net income/ Total Assets)
|
5.86%
|
9.86%
|
10.5%
|
12.8%
|
5.88%
|
2.36%
|
Assets
1 |
4,265
|
5,795
|
8,212
|
7,969
|
9,065
|
8,383
|
Book Value Per Share
2 |
100.0
|
116.0
|
138.0
|
166.0
|
180.0
|
186.0
|
Cash Flow per Share
2 |
1.360
|
1.300
|
5.140
|
4.570
|
1.960
|
4.750
|
Capex
1 |
308
|
129
|
98.8
|
350
|
595
|
467
|
Capex / Sales
|
6.09%
|
1.7%
|
1.3%
|
4.94%
|
6.85%
|
5.5%
|
Announcement Date
|
26/09/18
|
28/08/19
|
21/08/20
|
02/07/21
|
01/07/22
|
24/07/23
|
|
1st Jan change
|
Capi.
|
---|
| -13.53% | 140M | | +16.91% | 66.18B | | +1.64% | 49.24B | | +16.70% | 41.72B | | +22.58% | 26.16B | | +12.92% | 19.75B | | +2.79% | 17.5B | | -23.54% | 15.63B | | -6.24% | 15.46B | | +2.52% | 15.43B |
Other Specialty Chemicals
|